EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treatable Traits in Pregnant Women With Asthma: a Retrospective Study of Prevalence and Associations With Exacerbation and Poor Asthma Control

Esha Joshi, Peter G Gibson, Bronwyn K Brew, Megan E Jensen, Daniel Barker, Erin Nolan, Vanessa M McDonald, Vanessa E Murphy

The Journal of Allergy and Clinical Immunology: In Practice · 2026-09

DOI: 10.1016/j.jaip.2026.08.045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-09. Verfasst von Esha Joshi und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia; Breathing and Lung Health Research Program, Hun…. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Medical Research Future Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Treatable traits personalize asthma management, yet their prevalence and associations with exacerbations and asthma control in pregnancy are understudied. OBJECTIVE: To determine the prevalence of 18 treatable traits and their associations with exacerbations and asthma control in pregnant women with asthma. METHODS: We examined Breathing for Life Trial clinical records to identify 18 potential treatable traits from mid-pregnancy. Regression models adjusted for confounders determined associations with future exacerbations during pregnancy. In a subgroup, traits associated with asthma control were assessed at multiple time points during pregnancy using a generalized linear mixed model. RESULTS: Pregnant women (n = 761) with mild to moderate asthma exhibited a median of 36% of possible traits assessed. Prevalent treatable traits included no asthma action plan (84.2%), inhaler device polypharmacy (82.1%), and iron deficiency (70.4%). A history of exacerbation (adjusted odds ratio [OR] = aOR 2.47; 95% CI, 1.61-3.78; P < .002) and significant nausea (OR = 1.88; 95% CI, 1.24-2.85; P = .039) were associated with increased exacerbation whereas a history of exacerbation was associated with increasing exacerbations (adjusted incidence rate ratio = 2.26; 95% CI, 1.51-3.40; P = .002) after adjusting for confounders and multiple comparisons. In mid-pregnancy, inhaler device polypharmacy (OR = 2.72; 95% CI, 2.08-3.57; P = .002), current smoking (OR = 2.51; 95% CI, 1.36-4.63; P = .039), and a history of exacerbations (OR = 1.95; 95% CI, 1.26-3.02; P = .039) were associated with poorer asthma control. CONCLUSIONS: Behavioral and risk factor traits are common in asthma during pregnancy. A history of exacerbation and significant nausea were associated with increased exacerbation risk. Inhaler device polypharmacy, smoking, and a history of exacerbations were associated with poor asthma control in mid-pregnancy.

Schlagwörter

Stichwörter der Autor:innen

AsthmaAsthma controlBehavioral and risk factorExacerbationExtrapulmonaryPregnancyPulmonaryTreatable traits

Autor:innen und Institutionen

  • School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia; Breathing and Lung Health Research Program, Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
  • School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia; Breathing and Lung Health Research Program, Hunter Medical Research Institute, Newcastle, New South Wales, Australia;…
  • School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia; Data Sciences, Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
  • School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia; School of Nursing and Midwifery, University of Newcastle, Newcastle, New South Wales, Australia.
  • School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia; Breathing and Lung Health Research Program, Hunter Medical Research Institute, Newcastle, New South Wales, Australia.…

Förderung

  • National Health and Medical Research Council
  • Medical Research Future Fund

Zitieren

APA

Joshi, E., Gibson, P. G., Brew, B. K., Jensen, M. E., Barker, D., Nolan, E., McDonald, V. M., & Murphy, V. E. (2026). Treatable Traits in Pregnant Women With Asthma: a Retrospective Study of Prevalence and Associations With Exacerbation and Poor Asthma Control. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2026.08.045

Vancouver

Joshi E, Gibson PG, Brew BK, Jensen ME, Barker D, Nolan E, et al. Treatable Traits in Pregnant Women With Asthma: a Retrospective Study of Prevalence and Associations With Exacerbation and Poor Asthma Control. The Journal of Allergy and Clinical Immunology: In Practice. 2026. doi:10.1016/j.jaip.2026.08.045

BibTeX
@article{Joshi2026,
  author = {Joshi, Esha and Gibson, Peter G and Brew, Bronwyn K and Jensen, Megan E and Barker, Daniel and Nolan, Erin and McDonald, Vanessa M and Murphy, Vanessa E},
  title = {Treatable Traits in Pregnant Women With Asthma: a Retrospective Study of Prevalence and Associations With Exacerbation and Poor Asthma Control},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2026},
  doi = {10.1016/j.jaip.2026.08.045}
}
Kostenlos starten →